Skip to content

Drug interactions

Haloperidol + Pemigatinib

Severity: Moderate

Haloperidol and Pemigatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pemigatinib is a CYP3A4 substrate. Haloperidol is only a weak inhibitor, so the increase in exposure is expected to be small, but may worsen hyperphosphatemia-related and other adverse effects.

What this interaction means in plain words

Haloperidol and Pemigatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Haloperidol belongs to Central Nervous System; Pemigatinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by haloperidol reducing pemigatinib clearance.

What to do

Monitor for pemigatinib adverse effects and serum phosphate. Adjust the dose per labeling if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Haloperidol and Pemigatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Haloperidol with Pemigatinib?

MediHelp rates the interaction as moderate. Haloperidol and Pemigatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pemigatinib is a CYP3A4 substrate. Haloperidol is only a weak inhibitor, so the increase in exposure is expected to be small, but may worsen hyperphosphatemia-related and other adverse effects.

How serious is the interaction between Haloperidol and Pemigatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for pemigatinib adverse effects and serum phosphate. Adjust the dose per labeling if toxicity occurs.

What other medicines interact with Haloperidol?

MediHelp also lists interactions of Haloperidol with, for example, Dofetilide, Dronedarone, Ibutilide. The full list is on the Haloperidol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in